FibrOAT

Optimising gastrointestinal health is key to treating conditions that extend beyond the digestive tract.

As part of our range of prebiotic fibres, FibrOAT is a gluten free, high beta-glucan fibre, that nourishes the microbiome and has the unique function of positively modulating the blood lipid profile.

FibrOAT can also be taken in addition to FloraGenex, a prebiotic formulation which is an integral component of the G.E.M.M. Protocol.

Around 50 clinical trials have established the benefits of oat beta-glucan.

Overall, it has been shown that 3 grams daily can lower LDL cholesterol by 3-5% and total cholesterol by 2-4%, with the greatest reductions in diabetics and those with the highest cholesterol levels. Other studies show that around 4 grams oat beta-glucan per 30 grams available carbohydrate improve the glucose response.

FibrOAT can reduce appetite, assist gut health, nourish the gut microflora and modulate cardiometabolic function.

FibrOAT is a fine creamy-coloured soluble powder which thickens when added to liquid.

FibrOAT features:

1. Reduces LDL cholesterol and dietary and biliary cholesterol absorption.
2. Promotes epithelial barrier function.
3. Significant butyrate source which is the preferred fuel for colonocytes.
4. Immune-modulating via SCFA receptor GPR43.
5. Low intestinal gas production compared with inulin as the highest.

When to prescribe:

1. When there is an elevated blood lipid profile.
2. When you want to nourish and re-diversify the microbiome.
3. When immune function is suboptimal.
4. Where there is oxidative stress and digestive inflammation.
5. To increase satiety and promote normal laxation.
6. When excess gas production resulting from alternative prebiotic fibres is an issue.

Each 10 gram FibrOAT scoop contains:

Beta-Glucan (Avena sativa) as PromOat® (Gluten-free).

FibrOAT is 100% Swedish non-GMO oats produced to be gluten-free with gluten assayed below the limit of detection of 20 ppm – or 2 mg per 10 gram serve. A daily total gluten intake of <10 mg is considered unlikely to cause significant mucosal abnormalities in those with coeliac disease.